Showing results (101-110 of 128) with videos related to
Sort By:
Pageof 13
Liver International : Official Journal of the International Association for the Study of the Liver|January 17, 2024
Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort studyMin Kyung Park, Moon Haeng Hur, Hye-Sung Moon, et al.Digestive Diseases and Sciences|January 20, 2022
Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic DecompensationMin Kyung Park, Yun Bin Lee, Hyemi Moon, et al.JHEP Reports : Innovation in Hepatology|July 8, 2024
Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosisHyunjae Shin, Won-Mook Choi, Seung Up Kim, et al.The Tohoku Journal of Experimental Medicine|October 12, 2016
Prevalence and Risk Factors of Respiratory Viral Infections in Exacerbations of Chronic Obstructive Pulmonary DiseaseHyun Jung Kwak, Dong Won Park, Jee Eun Kim, et al.Clinical and Molecular Hepatology|November 25, 2025
Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysisJuhee Ahn, Moon Haeng Hur, Hyunjae Shin, et al.Canadian Journal of Gastroenterology & Hepatology|September 24, 2024
The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South KoreaSung Won Chung, Min Kyung Park, Xiao Zhang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 31, 2024
Stilbenoid derivatives as potent inhibitors of HIF-1α-centric cancer metabolism under hypoxiaTae-Hee Han, Joohan Lee, Dipesh S Harmalkar, et al.BMC Gastroenterology|March 26, 2022
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysisNa Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, et al.Scientific Reports|December 14, 2017
Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infectionYu-Jin Jung, Young-Tae Lee, Vu Le Ngo, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 11, 2025
Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosisYunmi Ko, Byeong Geun Song, Hyunjae Shin, et al.Pageof 13